TIAA FSB’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
TIAA FSB's MRNA Position: Q2 2023 in Review
TIAA FSB increased its Moderna (MRNA) stake by 2.4% in Q2 2023, buying an estimated $15.6K and bringing the position to 5,015 shares worth $609K. The position accounts for ﹤0.01% of the portfolio, ranked #389.
TIAA FSB first reported a position in MRNA in Q2 2022 and has held it in 5 quarters since. The position peaked at $956K in Q4 2022. 965 funds tracked by Wall St. Rank hold MRNA as of Q2 2023.
- TIAA FSB held 5,015 shares of Moderna worth $609K as of Q2 2023.
- TIAA FSB bought 117 Moderna shares in Q2 2023, an estimated $15.6K.
- Moderna made up ﹤0.01% of TIAA FSB's portfolio in Q2 2023, its #389 holding.
- TIAA FSB first reported a position in Moderna in Q2 2022 and has held it in 5 quarters since.
- TIAA FSB's Moderna position peaked at $956K in Q4 2022.
- 965 funds tracked by Wall St. Rank held Moderna as of Q2 2023.
Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.